Medical cannabis in France: a project still on hold
The medical cannabis project in France is experiencing a new slowdown. While many patients were hoping for a rapid and effective implementation, the project appears to be blocked once again within the Ministry of Health.
This situation is causing confusion among patient associations. For several years, France has been conducting experiments to evaluate the efficacy and safety of therapeutic cannabis. These tests were intended to help define a clear legal framework to facilitate access to treatments for people suffering from chronic pain or serious illnesses.
However, administrative decisions are slow to materialize. Health authorities still need to resolve complex issues, particularly the reimbursement of products by the national health insurance system and the prescription procedures for doctors. This lack of clarity leaves patients in a state of prolonged uncertainty.
For the moment, the ministry has not communicated a new, precise timeline. Stakeholders in the sector are now awaiting concrete announcements to see if medical cannabis will be able to become a reality accessible to all concerned French citizens in the coming months.